当前位置:主页 > 管理论文 > 绩效管理论文 >

2017医改畅想

发布时间:2018-04-04 16:07

  本文选题:药品定价 切入点:疾病诊断相关分组 出处:《中国卫生资源》2017年01期


【摘要】:根据当前医改形势,提出2017年的医改重点和改革路径:一是推动同类药品按照药品通用名制定统一医保支付标准,二是探索基于大数据的按疾病诊断相关分组(DRGs)付费,三是在系统比价的基础上进行医疗服务价格调整,四是提高家庭医生签约率,促进分级诊疗,五是建立科学的绩效考核和医生薪酬分配制度。
[Abstract]:According to the current situation of health care reform, this paper puts forward the key points and reform paths of health care reform in 2017: first, to promote the development of uniform medical insurance payment standards for similar drugs in accordance with the generic name of medicines; and second, to explore the payment of DRGsby disease diagnosis related groups based on big data.The third is to adjust the price of medical service on the basis of systematic price comparison, the fourth is to improve the contract rate of family doctors, to promote the classification of diagnosis and treatment, and the fifth is to establish a scientific system of performance appraisal and doctor's salary distribution.
【作者单位】: 上海市医学科学技术情报研究所上海市卫生发展研究中心;上海市人口与发展研究中心;复旦大学公共卫生学院;
【基金】:上海市第四轮公共卫生三年行动计划重点学科建设项目循证公共卫生与卫生经济学(15GWZK0901)
【分类号】:R197.1

【相似文献】

相关期刊论文 前1条

1 叶煜荣;;警惕“明降暗升”[J];中国医院院长;2007年Z1期



本文编号:1710682

资料下载
论文发表

本文链接:https://www.wllwen.com/guanlilunwen/jixiaoguanli/1710682.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户eb350***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com